CONTINUE TO SITE
OR WAIT null SECS
- Advertise
- Editorial Info
- Contact Us
- Terms & Conditions
- Privacy Policy
- Do Not Sell My Personal Information
© 2022 MJH Life Sciences™ and Formulary Watch. All rights reserved.
Antihypertensives demonstrate benefit in reducing Alzheimer's disease risk
Potassium-sparing diuretics reduced the risk of Alzheimer's disease (AD) by >70% in patients aged >64 years while other antihypertensive (AH) medications, including all diuretics, beta blockers, and dihydropyridine calcium channel blockers, were linked with somewhat smaller decreases in Alzheimer's risk.